News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Olin will acquire Huntsman in a $2.43 billion all-stock deal, targeting $400M+ in cost synergies.
  • Google will invest $1.5 billion to expand its Alabama data center campus through 2027.
  • Switzerland will host a US-Iran interim accord signing at Buergenstock on June 19 to end the Middle East war.
  • FBI announced arrests after a multi-state operation that prevented an alleged explosive-drone attack targeting the White House during a UFC event.
  • Netflix shares fell after Fox reportedly won a $22 billion bid for Roku, outbidding Netflix.
  • Gildan shares fell after a short-seller alleged years of negative organic growth and roughly $500 million of excess inventory.
  • Citi said U.S. equity positioning broadened but warned concentrated Nasdaq exposure is the primary near-term market vulnerability.

Latest Articles

Trump Media Sets Feb. 2, 2026 Record Date for Token Distribution

Trump Media Sets Feb. 2, 2026 Record Date for Token Distribution

Trump Media and Technology Group Corp. (DJT) confirmed a February 2, 2026 record date for distribution of a proposed digital token program. Eligible recipients will be ultimate beneficial owners of at least one whole share as of that date, including shareholders registered with the company transfer agent. The company said tokens will be non-transfe…

Parex Rebound - Momentum Meets a Crowded Short: A Tactical Long

Parex Rebound - Momentum Meets a Crowded Short: A Tactical Long

Parex Resources (PARXF) has threaded a series of higher moving averages, a bullish MACD and a rising RSI while short interest remains extremely high. This trade idea targets a momentum-driven rally into the mid-$17s with a defined stop under the 50-day moving average. High short interest means volatility can work for or against you - position sizin…

Cantor Fitzgerald Lifts Qualcomm Price Target to $160, Keeps Overweight Rating Amid Cautious 2026 Outlook

Cantor Fitzgerald Lifts Qualcomm Price Target to $160, Keeps Overweight Rating Amid Cautious 2026 Outlook

Cantor Fitzgerald raised its price target on Qualcomm to $160 while retaining an Overweight rating, even as it forecasts weaker revenue across handset and QCT segments for calendar 2026. The research house expects solid December-quarter results but projects guidance for the March quarter modestly below consensus and June guidance well below consens…

VerifyMe Regains Nasdaq Minimum Bid Compliance, Stock Opens Higher

VerifyMe Regains Nasdaq Minimum Bid Compliance, Stock Opens Higher

VerifyMe Inc. reported that it has satisfied Nasdaq’s minimum bid price requirement after its closing bid exceeded $1.00 for 10 consecutive business days from January 13 through January 29, 2026. The announcement came after a prior notification of non-compliance and preceded a 3.5% increase in premarket trading for the company’s shares.

France’s 2026 Budget Clears Parliament After Concessions, Targets 5% Deficit

France’s 2026 Budget Clears Parliament After Concessions, Targets 5% Deficit

France’s 2026 fiscal plan is set to pass as parliamentary no-confidence motions are expected to fail. The package seeks to narrow the deficit to 5% of GDP from an estimated 5.4% last year, after the government backed away from an earlier 4.7% target following concessions to the Socialist party. The plan combines extended levies on large firms, new …

Insmed: Don't Let Brensocatib Noise Obscure a BRINSUPRI Adoption Story

Insmed: Don't Let Brensocatib Noise Obscure a BRINSUPRI Adoption Story

Insmed shares have been knocked around by negative headlines on the development side, but the company already has a commercially approved DPP1 inhibitor, BRINSUPRI, with consensus peak sales potential near $5 billion. With a market cap of roughly $33.5 billion and supportive technicals, this trade idea buys the pullback into what we view as an othe…

William Blair Raises Palantir to Outperform, Citing AI Momentum Across Government and Commercial Workflows

William Blair Raises Palantir to Outperform, Citing AI Momentum Across Government and Commercial Workflows

William Blair moved Palantir Technologies Inc. (PLTR) from Market Perform to Outperform on Monday, pointing to sustained momentum in both government and commercial channels. The upgrade, issued before Palantir’s upcoming earnings, notes strong tracker data, large partnership expansions, and enterprise adoption, even as the stock has experienced a s…

Stephens Trims Target on Canadian National as Volume Outlook Softens

Stephens Trims Target on Canadian National as Volume Outlook Softens

Stephens reduced its 12-month price target for Canadian National Railway (CNI) to $100 from $105 while retaining an Equal Weight rating. The move follows Q4 2025 results that beat estimates on adjusted EPS and operating ratio, but the firm cited flat revenue ton mile guidance, macroeconomic and trade-policy uncertainty, and rising expenses that lim…